Advanced Oncotherapy plc (LON:AVO – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Price Performance
The company has a 50 day moving average price of GBX 1.75 and a 200 day moving average price of GBX 1.75. The company has a market capitalization of £9.49 million, a price-to-earnings ratio of -25.00 and a beta of 0.06. The company has a current ratio of 1.26, a quick ratio of 0.13 and a debt-to-equity ratio of 98.71.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Featured Stories
- Five stocks we like better than Advanced Oncotherapy
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Battle of the Retailers: Who Comes Out on Top?
- The How and Why of Investing in Gold Stocks
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
